# M1 paper language — prospective heading scenario

RegBridge M1 evaluates a **prospective forward-compatibility research scenario** for controlled
FDA/CDER examples. As of the recorded M1 snapshot, FDA forward compatibility is
`not_operational`. The experiment therefore tests whether the proposed typed graph and executable
constraint architecture can explain a future compatibility risk; it does not claim that sponsors
can currently execute the described workflow operationally.

The M1 rule maps only `3.2.S.1.1`, `3.2.S.1.2`, and `3.2.S.1.3` to `3.2.S.1`. For those exact
inputs it returns `REUSE_WITH_NEW_CONTEXT` and proposes
`CREATE_NEW_CONTEXT_GROUP_AND_SUSPEND_LEGACY_CONTENT`, while retaining document reuse through its
identifier without resubmission of the physical file or document element. The implementation does
not infer a nearest available parent.

Source spans and the mechanical derivation were verified/adjudicated by research author
`author-01`. These are author-adjudicated research labels, not expert regulatory ground truth.
`expert_validated` is `false`, and no FDA approval, filing-acceptance prediction, or professional
regulatory validation is claimed.
